Thesan Pharmaceuticals

About:

Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.

Website: http://www.thesanpharma.com

Top Investors: SV Health Investors, Novartis Venture Fund, Ipsen, Lundbeckfonden Ventures, Novo Ventures

Description:

Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Until recently, there has been comparatively limited innovation in the field of dermatology, where many companies have focused on the reformulation of existing drugs often resulting in marginal patient benefit. In contrast, Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients.

Total Funding Amount:

$65M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)thesanpharma.com

Founders:

Daniele Piomelli, Edward Monaghan

Number of Employees:

11-50

Last Funding Date:

2016-01-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai